Cargando…

Esophageal location of mantle cell lymphoma

Detalles Bibliográficos
Autor principal:	Michopoulos, Spyros
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hellenic Society of Gastroenterology 2016
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5049571/ https://www.ncbi.nlm.nih.gov/pubmed/27708530 http://dx.doi.org/10.20524/aog.2016.0080

Ejemplares similares

Mantle cell lymphoma with skin involvement
por: Kalińska-Bienias, Agnieszka, et al.
Publicado: (2015)

Pyoderma gangrenosum associated with mantle cell lymphoma
por: Padhi, Tanmay, et al.
Publicado: (2016)

Acute dyspnoea and single tracheal localisation of mantle cell lymphoma
por: Ianotto, Jean-Christophe, et al.
Publicado: (2010)

Tumor flare reaction in a patient with mantle cell lymphoma
por: Kayar, Yusuf, et al.
Publicado: (2014)

Development of highly aggressive mantle cell lymphoma after sofosbuvir treatment of hepatitis C
por: Lin, R J, et al.
Publicado: (2016)

Discovery and characterization of a novel CCND1/MRCK gene fusion in mantle cell lymphoma
por: Masamha, Chioniso Patience, et al.
Publicado: (2016)

Differential expression, localization and activity of MARCKS between mantle cell lymphoma and chronic lymphocytic leukemia
por: Vargova, J, et al.
Publicado: (2016)

Clinical activity of abemaciclib in patients with relapsed or refractory mantle cell lymphoma – a phase II study
por: Morschhauser, Franck, et al.
Publicado: (2020)

Zanubrutinib monotherapy in relapsed/refractory mantle cell lymphoma: a pooled analysis of two clinical trials
por: Zhou, Keshu, et al.
Publicado: (2021)

A multicenter phase II study of bendamustine, rituximab, and cytarabine (BRAC) for relapsed or refractory patients with follicular lymphoma or mantle cell lymphoma
por: Nakamura, Nobuhiko, et al.
Publicado: (2022)

Prolonged lymphocytopenia after bendamustine therapy in patients with relapsed or refractory indolent B-cell and mantle cell lymphoma
por: Saito, H, et al.
Publicado: (2015)

Pirtobrutinib and venetoclax combination overcomes resistance to targeted and chimeric antigen receptor T-cell therapy in aggressive mantle cell lymphoma
por: Liu, Yang, et al.
Publicado: (2022)

Combinatorial drug screening identifies synergistic co-targeting of Bruton's tyrosine kinase and the proteasome in mantle cell lymphoma
por: Axelrod, M, et al.
Publicado: (2014)

Final analysis of a phase II study of ibrutinib in Japanese patients with relapsed/refractory mantle cell lymphoma
por: Maruyama, Dai, et al.
Publicado: (2019)

Does Ibrutinib impact outcomes of viral infection by SARS-CoV-2 in mantle cell lymphoma patients?
por: Alsuliman, Tamim, et al.
Publicado: (2021)

The antibody drug conjugate VLS-101 targeting ROR1 is effective in CAR T-resistant mantle cell lymphoma
por: Jiang, Vivian Changying, et al.
Publicado: (2021)

TRES, a validated three-factor comorbidity score, is associated with survival in older patients with mantle cell lymphoma
por: Gordon, Max J., et al.
Publicado: (2023)

Real‐world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis
por: Yi, Jun Ho, et al.
Publicado: (2021)

Severe CMV Infection after Chemo-Immunotherapy with Dose-Reduced Bendamustine and Rituximab in a Mantle Cell Lymphoma Old Patient
por: Magliano, Gabriele, et al.
Publicado: (2021)

Treatment patterns and real-world effectiveness of rituximab maintenance in older patients with mantle cell lymphoma: a population-based analysis
por: Di, Mengyang, et al.
Publicado: (2023)

Repeated Infusions of Brexucabtagene-autoleucel in Relapsed/Refractory Mantle Cell Lymphoma
por: Aydilek, Enver, et al.
Publicado: (2023)

Targeting FcγRIIB by antagonistic antibody BI-1206 improves the efficacy of rituximab-based therapies in aggressive mantle cell lymphoma
por: Jiang, Vivian Changying, et al.
Publicado: (2022)

Primary Non-Hodgkin's Lymphoma of the Duodenum: An Uncommon Location
por: Ravikanth, Reddy, et al.
Publicado: (2019)

Non-indolent mantle cell lymphoma at a single public hospital in Brazil: real world first-line treatment cohort study data
por: Brasil, Sergio Augusto Buzian, et al.
Publicado: (2020)

Mantle cell lymphoma presenting as diffuse esophageal, gastric, and duodenal bulb polyposis
por: Nopjaroonsri, Papatsakorn, et al.
Publicado: (2019)

Alkylating agents induce histone H3K18 hyperacetylation and potentiate HDAC inhibitor-mediated global histone acetylation and cytotoxicity in mantle cell lymphoma
por: Hiraoka, N, et al.
Publicado: (2013)

Long‐term follow‐up after R‐High CHOP/CHASER/LEED with Auto‐PBSCT in untreated mantle cell lymphoma—Final analysis of JCOG0406
por: Ogura, Michinori, et al.
Publicado: (2023)

Low-grade follicular lymphoma involvement of the bone marrow with a mixed paratrabecular, diffuse, and massive pattern expressing typical mantle cell lymphoma immunophenotype CD23−/FMC7+: a case report
por: Kim, Jaewook, et al.
Publicado: (2018)

CAR T-cell therapy for mantle cell lymphoma with central nervous system relapse
por: Vu, Khoan, et al.
Publicado: (2022)

Smoldering mantle cell lymphoma
por: Ye, Haige, et al.
Publicado: (2017)

Identification of the SRC-family tyrosine kinase HCK as a therapeutic target in mantle cell lymphoma
por: Lantermans, Hildo C., et al.
Publicado: (2020)

Cutaneous Involvement of Mantle Cell Lymphoma: Report of Two Cases with Dermatoscopic Features
por: Akay, Bengü Nisa, et al.
Publicado: (2022)

Robust CRISPR-Cas9 Genetic Editing of Primary Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma Cells
por: Mateos-Jaimez, Judith, et al.
Publicado: (2023)

Survival in mantle cell lymphoma after frontline treatment with R-bendamustine, R-CHOP and the Nordic MCL2 regimen – a real world study on patients diagnosed in Sweden 2007-2017
por: Albertsson-Lindblad, Alexandra, et al.
Publicado: (2021)

Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma
por: Iacoboni, Gloria, et al.
Publicado: (2022)

Cutaneous Involvement as a First Sign of CD5(-) Blastoid Mantle Cell Lymphoma
por: Zekey, Emre, et al.
Publicado: (2023)

The microenvironment of classical Hodgkin lymphoma: heterogeneity by Epstein–Barr virus presence and location within the tumor
por: Wu, R, et al.
Publicado: (2016)

Primary gastric mantle cell lymphoma
por: Petranovic, Duska, et al.
Publicado: (2012)

Tracheobronchial involvement of mantle cell lymphoma
por: Tong, Lin, et al.
Publicado: (2018)

Mantle Cell Lymphoma Case Report
por: Podzolkov, V.I., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ln9crmfprd12mh30obgcta8ig3